Loading clinical trials...
Loading clinical trials...
A Phase IV Study to Investigate the Effects of Varied Remifentanil Concentrations on Propofol Requirements for Loss of Consciousness, Response to Painful Stimuli, Bispectral Index and Associated Haemodynamic Changes
Conditions
Interventions
Remifentanil
Propofol
+1 more
Locations
1
Hong Kong
Queen Mary Hospital
Pok Fu Lam, Hong Kong
Start Date
February 1, 2015
Primary Completion Date
August 1, 2015
Completion Date
August 1, 2015
Last Updated
March 11, 2016
Lead Sponsor
The University of Hong Kong
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions